Ideaya Biosciences Stock Buy Hold or Sell Recommendation
| IDYA Stock | USD 26.60 1.06 4.15% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Ideaya Biosciences is 'Cautious Hold'. Macroaxis provides Ideaya Biosciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding IDYA positions.
Check out Ideaya Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide. In addition, we conduct extensive research on individual companies such as Ideaya and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Ideaya Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
Ideaya |
Execute Ideaya Biosciences Buy or Sell Advice
The Ideaya recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Ideaya Biosciences. Macroaxis does not own or have any residual interests in Ideaya Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Ideaya Biosciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Ideaya Biosciences Trading Alerts and Improvement Suggestions
| Ideaya Biosciences generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 23.39 M. Net Loss for the year was (112.96 M) with loss before overhead, payroll, taxes, and interest of (38.6 M). | |
| Ideaya Biosciences currently holds about 268.62 M in cash with (115.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.83. | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: IDEAYA Biosciences Now Covered by Analysts at Stephens |
Ideaya Biosciences current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Ideaya analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Ideaya analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Ideaya Biosciences Returns Distribution Density
The distribution of Ideaya Biosciences' historical returns is an attempt to chart the uncertainty of Ideaya Biosciences' future price movements. The chart of the probability distribution of Ideaya Biosciences daily returns describes the distribution of returns around its average expected value. We use Ideaya Biosciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Ideaya Biosciences returns is essential to provide solid investment advice for Ideaya Biosciences.
| Mean Return | -0.56 | Value At Risk | -5.09 | Potential Upside | 4.15 | Standard Deviation | 2.93 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Ideaya Biosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Ideaya Stock Institutional Investors
| Shares | Adage Capital Partners Gp Llc | 2024-06-30 | 2.1 M | Holocene Advisors, Lp | 2024-06-30 | 1.9 M | Geode Capital Management, Llc | 1.8 M | Pictet Asset Manangement Sa | 2024-06-30 | 1.6 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.6 M | Citadel Advisors Llc | 2024-06-30 | 1.5 M | Bvf Inc | 2024-09-30 | 1.4 M | Fiera Capital Corporation | 2024-06-30 | 1.3 M | Sofinnova Ventures | 2024-06-30 | 1.2 M | Fmr Inc | 2024-09-30 | 12.6 M | Blackrock Inc | 2024-06-30 | 6.8 M |
Ideaya Biosciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Ideaya Biosciences or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Ideaya Biosciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Ideaya stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.74 | |
β | Beta against Dow Jones | 1.69 | |
σ | Overall volatility | 2.92 | |
Ir | Information ratio | -0.23 |
Ideaya Biosciences Volatility Alert
Ideaya Biosciences exhibits very low volatility with skewness of -0.44 and kurtosis of 0.75. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Ideaya Biosciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Ideaya Biosciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Ideaya Biosciences Fundamentals Vs Peers
Comparing Ideaya Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Ideaya Biosciences' direct or indirect competition across all of the common fundamentals between Ideaya Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Ideaya Biosciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Ideaya Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Ideaya Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Ideaya Biosciences to competition |
| Fundamentals | Ideaya Biosciences | Peer Average |
| Return On Equity | -0.21 | -0.31 |
| Return On Asset | -0.16 | -0.14 |
| Operating Margin | (57.31) % | (5.51) % |
| Current Valuation | 1.31 B | 16.62 B |
| Shares Outstanding | 86.43 M | 571.82 M |
| Shares Owned By Insiders | 1.03 % | 10.09 % |
| Shares Owned By Institutions | 98.97 % | 39.21 % |
| Number Of Shares Shorted | 9.31 M | 4.71 M |
| Price To Earning | (2.17) X | 28.72 X |
| Price To Book | 1.87 X | 9.51 X |
| Price To Sales | 586.20 X | 11.42 X |
| Revenue | 23.39 M | 9.43 B |
| Gross Profit | (38.6 M) | 27.38 B |
| EBITDA | (130.42 M) | 3.9 B |
| Net Income | (112.96 M) | 570.98 M |
| Cash And Equivalents | 268.62 M | 2.7 B |
| Cash Per Share | 6.83 X | 5.01 X |
| Total Debt | 2.87 M | 5.32 B |
| Debt To Equity | 0.02 % | 48.70 % |
| Current Ratio | 4.69 X | 2.16 X |
| Book Value Per Share | 13.67 X | 1.93 K |
| Cash Flow From Operations | (115.22 M) | 971.22 M |
| Short Ratio | 12.62 X | 4.00 X |
| Earnings Per Share | (2.33) X | 3.12 X |
| Target Price | 54.87 | |
| Number Of Employees | 124 | 18.84 K |
| Beta | 0.86 | -0.15 |
| Market Capitalization | 2.3 B | 19.03 B |
| Total Asset | 649.32 M | 29.47 B |
| Retained Earnings | (348.36 M) | 9.33 B |
| Working Capital | 505.53 M | 1.48 B |
| Current Asset | 93.24 M | 9.34 B |
| Current Liabilities | 6.51 M | 7.9 B |
Note: Disposition of 5000 shares by Throne Jason of Ideaya Biosciences at 13.34 subject to Rule 16b-3 [view details]
Ideaya Biosciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Ideaya . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Ideaya Biosciences Buy or Sell Advice
When is the right time to buy or sell Ideaya Biosciences? Buying financial instruments such as Ideaya Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Ideaya Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Defense Thematic Idea Now
Defense
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Defense theme has 16 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Defense Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Ideaya Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ideaya Biosciences. If investors know Ideaya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ideaya Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.33) | Revenue Per Share 0.051 | Quarterly Revenue Growth (0.03) | Return On Assets (0.16) | Return On Equity (0.21) |
The market value of Ideaya Biosciences is measured differently than its book value, which is the value of Ideaya that is recorded on the company's balance sheet. Investors also form their own opinion of Ideaya Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Ideaya Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ideaya Biosciences' market value can be influenced by many factors that don't directly affect Ideaya Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ideaya Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ideaya Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ideaya Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.